 |
市場調查報告書
商品編碼
1391983
口溶錠(ODT) 市場：依藥物類別、依疾病適應症、依年齡層、依配銷通路、按地區Orodispersible Tablets Market, By Drug Class, By Disease Indication, By Age Group, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
預計2023年全球口溶錠市場規模將達92.9億美元。在預測期內，全球口腔崩壞錠劑市場預計將呈現約10.7%的年複合成長率(CAGR)。到2030年，市場規模預計將達到189.2億美元。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2022年 | 2023年市場規模 | 92.9億美元 |
| 實績資料 | 2018-2021 | 預測期 | 2023-2030 |
| 預測期年複合成長率 | 10.70% | 2030年市場規模預測 | 189.2億美元 |
圖 1.口溶錠的全球市場佔有率（%），按地區分類，2023 年
口溶錠(ODT) 是固態單位劑型，無需咀嚼或喝水即可在口腔中快速崩壞或溶解。這種劑型的需求正在增加，特別是在吞嚥傳統錠劑困難或不舒服的兒童和老年患者群體中。 ODT 由多種賦形劑配製而成，包括粘合劑和崩壞。最常見的粘合劑是甲基丙烯酸共聚物，其具有較高的內部強度，可以支持高劑量藥物的配方。它們還具有防水性，並且比標準錠劑對濕氣更敏感。最常見的崩壞是甘露醇和阿斯巴甜。口溶錠( ODT) 是專門設計用於在口腔中快速崩壞（通常在幾秒鐘內崩解）的劑型。這種獨特的配方主要旨在提高依從性和便利性，特別是對於吞嚥傳統口服固體製劑（如錠劑和膠囊）有困難的患者。 ODT 通常用於給藥，特別是那些需要快速起效的藥物，例如止痛藥、抗組織胺藥物和用於治療各種疾病的藥物。
市場動態：
全球老年人口的增加預計將推動全球口溶錠市場的成長。由於可用性和便利性，老年人更喜歡自我給藥給藥。對老年人醫療保健設施的日益關注也推動了市場的成長。
然而，價格壓力正在增加，預計將在不久的將來阻礙全球口溶錠市場的成長。
本研究的主要特點
- 本報告對全球口溶錠市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率。
- 它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
- 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
- 它根據公司亮點、產品系列、主要亮點、業績和策略等參數，介紹了全球口溶錠市場的主要企業。
- 該報告的見解使行銷人員和經營團隊負責人就未來的產品發布、類型升級、市場擴張和行銷策略做出資訊的決策。
- 全球口溶錠市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
- 透過用於分析全球口溶錠市場的各種策略矩陣，將促進相關人員的決策。
目錄
第1章 研究目的與前提
- 研究目標
- 假設
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章 市場動態、法規及趨勢分析
- 促進因素
- 市場動態
- 慢性病盛行率增加
- 藥物傳輸技術的進步
- 提高患者的依從性和便利性
- 越來越注重以病人為中心的護理
- 抑制因素
- 開發和製造成本高
- 有限的藥物相容性和配方選擇
- 機會
- 對個人化醫療的需求不斷增加
- 更多採用數位健康解決方案
- 開發創新的掩味技術
- 專注於速溶製劑
- 影響分析
- 主要亮點
- 監管場景
- 產品發布/核准
- PEST分析
- 波特的分析
- 併購場景
第4章 全球口溶錠市場－冠狀病毒（COVID-19）大流行的影響
- 新型冠狀病毒感染疾病（COVID-19）的流行病學
- 供需面分析
- 經濟影響
第5章 全球口溶錠市場，依藥物類別，2018-2030
- 止痛藥
- 止吐藥
- 抗精神病藥
- 發炎藥
- 鎮靜劑/安眠藥
- 抗高血壓
- 其他
第6章 全球口溶錠市場（依疾病適應症），2018-2030
- 疼痛管理
- 過敏及呼吸道疾病
- 神經系統疾病
- 胃腸道疾病
- 心血管疾病
- 其他
第7章 全球口溶錠市場，依年齡層別，2018-2030
- 兒童患者
- 成年患者
- 老年病人
第8章 全球口溶錠市場，依配銷通路，2018-2030
- 醫院藥房
- 零售藥房
- 線上藥房
第9章 2018-2030年全球口溶錠市場（按地區）
- 北美洲
- 美國
- 加拿大
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太地區
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 中東和非洲
- GCC
- 以色列
- 北非
- 中部非洲
- 其他中東和非洲
第10章 競爭形勢
- AstraZeneca PLC
- GlaxoSmithKline PLC
- Novartis International AG
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- Merck & Co., Inc.
- Pfizer Inc.
- Cipla Limited
- Reddy's Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- Lupin Pharmaceuticals, Inc.
- Torrent Pharmaceuticals Ltd.
- F.Hoffmann-La Roche Ltd.
- Eisai Co., Ltd.
- Takeda Pharmaceutical Company Limited
第11章章節
- 調查方法
- 關於出版商
簡介目錄
Product Code: CMI5745
Global orodispersible tablets market is estimated to be valued US$ 9.29 billion in 2023. Over the forecast period, global orodispersible tablets market is expected to exhibit a compound annual growth rate (CAGR) of approximately 10.7%. By 2030, the market size is anticipated to reach USD 18.92 billion.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 9.29 Bn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 10.70% | 2030 Value Projection: | US$ 18.92 Bn |
Figure 1. Global Orodispersible Tablets Market Share (%), By Region, 2023
Orodispersible tablets (ODTs) are solid unit dosage forms that disintegrate or dissolve rapidly in the mouth without chewing and without the need for water. The demand for this dosage form has been increasing, especially in pediatric and geriatric patient populations who find swallowing conventional tablets difficult or uncomfortable. ODTs are formulated from various excipients including binders and disintegrants. The most common binders are methacrylic acid copolymers that have high internal strength to support the formulation of high dose drugs. These also have the property of water resistance, and are less sensitive to moisture than standard tablet formulations. The most popular disintegrants are mannitol and aspartame. Orodispersible tablets (ODTs) are a specialized dosage form designed to disintegrate rapidly in the oral cavity, often within a matter of seconds, without the need for additional water or chewing. This unique pharmaceutical formulation is primarily intended to improve patient compliance and convenience, particularly for those who have difficulty swallowing traditional solid oral dosage forms like tablets or capsules. ODTs are commonly used to administer medications, including pain relievers, antihistamines, and treatments for various medical conditions, especially when quick onset of action is essential.
Market Dynamics:
Increasing geriatric population across the globe is anticipated to drive growth of the global orodispersible tablets market. Elderly people prefer self-administration of medications for easy accessibility and convenience. Rising focus on healthcare facilities for the elderly also boosts the market growth.
However, increased pricing pressure is projected to hinder growth of the global orodispersible tablets market in the near future.
Key features of the study:
- This report provides in-depth analysis of the global orodispersible tablets market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global orodispersible tablets market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include AstraZeneca PLC, GlaxoSmithKline PLC, Novartis International AG, Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Pfizer Inc., Cipla Limited, Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Inc., Torrent Pharmaceuticals Ltd., F. Hoffmann-La Roche Ltd., Eisai Co., Ltd., and Takeda Pharmaceutical Company Limited
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global orodispersible tablets market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global orodispersible tablets market
Detailed Segmentation:
- By Drug Class:
- Analgesics
- Antiemetics
- Antipsychotics
- Anti-inflammatory Drugs
- Sedatives/Hypnotics
- Antihypertensives
- Others
- By Disease Indication:
- Pain Management
- Allergy and Respiratory Disorders
- Neurological Disorders
- Gastrointestinal Disorders
- Cardiovascular Disorders
- Others
- By Age Group:
- Pediatric Patients
- Adult Patients
- Geriatric Patients
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East &Africa
- Company Profiles:
- AstraZeneca PLC
- GlaxoSmithKline PLC
- Novartis International AG
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- Merck & Co., Inc.
- Pfizer Inc.
- Cipla Limited
- Dr. Reddy's Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- Lupin Pharmaceuticals, Inc.
- Torrent Pharmaceuticals Ltd.
- F. Hoffmann-La Roche Ltd.
- Eisai Co., Ltd.
- Takeda Pharmaceutical Company Limited
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Orodispersible Tablets, By Drug Class
- Market Orodispersible Tablets, By Disease Indication
- Market Orodispersible Tablets, By Age Group
- Market Orodispersible Tablets, By Distribution Channel
- Market Orodispersible Tablets, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Market Dynamics
- Increasing Prevalence of Chronic Diseases
- Technological Advancements in Drug Delivery
- Enhanced Patient Compliance and Convenience
- Growing Focus on Patient-Centered Care
- Restraints
- High Development and Manufacturing Costs
- Limited Drug Compatibility and Formulation Options
- Opportunities
- Increasing Demand for Personalized Medicine
- Rising Adoption of Digital Health Solutions
- Development of Innovative Taste-Masking Techniques
- Focus on Fast-Dissolving Formulations
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Orodispersible Tablets Market- Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Orodispersible Tablets Market, By Drug Class, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Antiemetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Antipsychotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Anti-inflammatory Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Sedatives/Hypnotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Antihypertensives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
6. Global Orodispersible Tablets Market, By Disease Indication, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
- Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Allergy and Respiratory Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Gastrointestinal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Cardiovascular Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
7. Global Orodispersible Tablets Market, By Age Group, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2023- 2030
- Segment Trends
- Pediatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Adult Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Geriatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
8. Global Orodispersible Tablets Market, By Distribution Channel, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
9. Global Orodispersible Tablets Market, By Region, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- GCC
- Israel
- North Africa
- Central Africa
- Rest of Middle East & Africa
10. Competitive Landscape
- AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline PLC
- Novartis International AG
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- Merck & Co., Inc.
- Pfizer Inc.
- Cipla Limited
- Reddy's Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- Lupin Pharmaceuticals, Inc.
- Torrent Pharmaceuticals Ltd.
- F.Hoffmann-La Roche Ltd.
- Eisai Co., Ltd.
- Takeda Pharmaceutical Company Limited
- Analyst Views
11. Section
- Research Methodology
- About us
02-2729-4219
+886-2-2729-4219
